LAKE FOREST, Calif.--(BUSINESS WIRE)--Nov. 22, 2005--I-Flow Corporation (NASDAQ:IFLO) announced today that the Company has partnered with the University of Minnesota (U of MN) to conduct an animal study to evaluate the promise of antimicrobial benefits of ON-Q(R). This will replace a previous study launched in June in partnership with Tulane University Health Sciences Center, which was halted abruptly, due to the effects of Hurricane Katrina, before results could be collected. The new study at the U of MN mirrors the design of the one at Tulane, and will involve one of the original investigators, Dr. Bruce Dunn, to maintain continuity.
